Detalhe da pesquisa
1.
The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial.
J Card Fail
; 28(5): 778-786, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933097
2.
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
Eur Heart J
; 42(6): 684-696, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215209
3.
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.
Cardiovasc Diabetol
; 20(1): 163, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372849
4.
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
ESC Heart Fail
; 11(1): 209-218, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939716
5.
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
Heart
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729636
6.
Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity.
Clin Res Cardiol
; 112(8): 1077-1086, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894788
7.
Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure.
ESC Heart Fail
; 9(5): 3009-3018, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35736536
8.
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
Eur J Heart Fail
; 24(9): 1559-1568, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703355
9.
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
Eur J Heart Fail
; 24(5): 771-778, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199421
10.
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.
Eur Heart J Cardiovasc Pharmacother
; 8(2): 149-156, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822033
11.
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
Eur J Heart Fail
; 24(2): 321-331, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841615
12.
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
ESC Heart Fail
; 9(6): 4352-4357, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065795
13.
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
JACC Heart Fail
; 9(4): 268-277, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549556
14.
High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
Cardiovasc Res
; 116(1): 91-100, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350553
15.
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
Eur J Heart Fail
; 22(9): 1711-1723, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31950604
16.
Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure.
Eur J Heart Fail
; 21(7): 904-916, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666769
17.
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?
Cardiovasc Res
; 119(14): e149-e151, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850512
18.
Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis.
ESC Heart Fail
; 10(2): 1492-1496, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811158
19.
Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure.
Heart
; 101(14): 1149-58, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26006717